Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy

All NewsSeptember 16, 2025

FDA warns Hims & Hers that its semaglutide products are misbranded due to misleading claims and asks for corrective steps within 15 days.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent